CAS: 504-78-9; Thiazolidine

该化合物是因其独特的化学特性而闻名的多用途有机化合物,具有高度稳定性,极好的溶解性以及多种反应性特征,这些特征使其在各种应用中具有价值,包括制药,农用化学品和材料科学. 它们能够形成稳定的环状并参与各种化学转化,在药物发现和物质开发方面有着巨大的优势.

结构式图片

相似化合物

14446-47-0 148312-55-4 96-53-7

欧盟法规

REACH注册ECHA物质C&L通报REACH预注册

上下游产品

CAS号50-00-0 甲醛 | CAS号156-57-0 半胱胺盐酸盐 | CAS号60-23-1 β-巯基乙胺 | CAS号33744-33-1 2-(methylamino)... | CAS号107-35-7 牛磺酸 | CAS号148312-53-2 N,4-dicycloprop... | CAS号89656-25-7 N-tert-butyl-1-... | CAS号52837-50-0 (9CI)-3-(氯乙酰基)-噻唑烷 | CAS号50916-00-2 1,3-thiazolidin... | CAS号51-85-4 胱胺

合成工艺路线路线简述

    聚合甲醛,巯基乙胺置于phosphate Buffer体系中,用 水 作为反应溶剂,化学反应 0.5H,反应生成 四氢噻唑
    参考文献:醛/半胱胺模型系统中噻唑烷形成的机理研究.
    标题:醛/半胱胺模型系统中噻唑烷形成的机理研究.
    摘要:提出了一种机制来阐明在醛/半胱胺模型系统中噻唑烷的形成.缓冲液可显着促进甲醛和半胱胺形成噻唑烷.磷酸盐趋于稳定形成的一级碳正离子,这可能会由于氨基氮对活性炭的攻击而导致环化反应完成.通过除去水分子,质子溶剂进一步增强了噻唑烷的形成.磷酸根离子催化的氧化还原反应导致噻唑烷通过氢化物转移转化为相应的噻唑啉.
    DOI:10.1021/jf9705633

    海关参考信息

    专利信息


    专利号:US-12421534-B2
    优先权日:2021-11-10
    标 题 :Engineered enzymes and method for the synthesis of diverse tyrosine analogs
    发明人:ALMHJELL PATRICK J; ARNOLD FRANCES H
    权利人:CALIFORNIA INST OF TECHN
    摘要:Provided herein is an engineered tryptophan synthase β-subunit (TrpB) that catalyzes the synthesis of tyrosine, tyrosine analogs, or salts thereof. Also provided herein are methods for preparing tyrosine, tyrosine analogs, or a salt thereof using the engineered TrpB described herein.

    专利号:US-11161827-B2
    优先权日:2019-04-05
    标 题 :Catalytic systems for stereoselective synthesis of chiral amines by enantiodivergent radical C—H amination
    发明人:Zhang xiao-xiang; Lang kai
    权利人:TRUSTEES BOSTON COLLEGE; THE TRUSTEES OF BOSTON COLLEGE
    摘要:In one aspect, the disclosure relates to a mode of asymmetric induction in radical processes based on sequential combination of enantiodifferentiative H-atom abstraction and stereoretentive radical substitution. Also disclosed is an asymmetric system for stereoselective synthesis of strained 5-membered cyclic sulfamides via radical 1,5-C—H amination of sulfamoyl azides. The disclosed metalloradical system can control the degree and sense of asymmetric induction in the catalytic radical C—H amination in a systematic manner. The disclosed system is applicable to a broad scope of substrates with different types of C(sp 3 )—H bonds and exhibits reactivity and selectivity, providing access to both enantiomers of useful 5-membered cyclic sulfamides in a highly enantioenriched form. Also disclosed are catalysts useful in these processes. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.

    专利号:US-7589170-B1
    优先权日:1998-09-25
    标题 :Synthesis of cyclic peptides
    发明人:SMYTHE MARK LESLIE; MEUTERMANS WIM DENIS FRANS; BOURNE GREGORY THOMAS; MCGEARY ROSS PETER
    权利人:UNIV QUEENSLAND
    摘要:This invention relates to methods for preparing cyclic peptides and peptidomimetic compounds in solution and bound to solid supports, and to cyclic peptide or peptidomimetic libraries for use in drug screening programs. In particular, the invention relates to a generic strategy for synthesis of cyclic peptides or peptidomimetics that enables the efficient synthesis under mild conditions of a wide variety of desired compounds. Two approaches were evaluated for their improvements in solution and solid phase synthesis of small cyclic peptides: positioning reversible N-amide substituents in the sequence; and applying native ligation chemistry in an intramolecular sense. Systematic investigation of the effects of preorganising peptides prior to cyclisation by using peptide cyclisation auxiliaries, and developing new linkers and peptide cyclisation auxiliaries to aid cyclic peptide synthesis gives surprising improvements in both yields and purity of products compared to the prior art methods. The combination of these technologies provides a powerful generic approach for the solution and solid phase synthesis of small cyclic peptides. The ring contraction and N-amide substitution technology of the invention provide improved methods for the synthesis of cyclic peptides and peptidomimetics. When used in conjunction with linker strategies, this combination provides solid-phase avenues to cyclic peptides and peptidomimetics.

    专利号:US-2024092821-A1
    优先权日:2020-03-31
    标题:Synthesis of oligonucleotides and related compounds
    发明人:ZHONG MINGHONG; JIN YI; GALA DINESH; PRHAVC MARIJA
    权利人:JANSSEN BIOPHARMA INC
    摘要:Methods of synthesizing oligonucleotides via new intermediates on a cleavable support having an azidomethyl moiety are disclosed. The method comprises multiple reaction cycles, each of which comprises sequential coupling a nucleoside or oligonucleotide subunit on a cleavable support having an azidomethyl moiety and a nucleoside phosphoramidite or an oligonucleotide phosphoramidite, capping, oxidation/thiolation and deblocking; followed by orthogonal cleavage of the azidomethyl support while keeping all other protecting groups intact. The method can be used in combination with a support moiety for either solid phase or liquid phase oligo synthesis. The soluble support facilitates homogeneous reactions and efficient separations by simple precipitation. The methods also provide novel intermediates useful in the synthesis of oligonucleotide conjugates.

    专利号:US-2021107859-A1
    优先权日:2018-04-06
    标题 :A process for the synthesis of carbon labeled organic compounds
    发明人:AUDISIO DAVIDE; CANTAT THIBAULT; DESTRO GIANLUCA
    权利人:COMMISSARIAT ENERGIE ATOMIQUE
    摘要:A process for the synthesis of a carbon labeled organic compound containing a carbon labeled carboxyl group is described. A method of using carbon labeled organic compounds containing a carbon labeled carboxyl group according to the present disclosure; a process for manufacturing labeled pharmaceuticals and agrochemicals comprising synthesis of carbon labeled organic compounds containing a carbon labeled carboxyl group according to the present disclosure; and a process for producing tracers comprising synthesis of carbon labeled organic compounds containing a carbon labeled carboxyl group according to the present disclosure are also described.

    专利号:US-10751419-B2
    优先权日:2014-05-01
    标题:Method for synthesis of reactive conjugate clusters
    发明人:MIGAWA MICHAEL T; YU JINGHUA; WAN W BRAD; PATEL SAYTEN P; VASQUEZ GUILLERMO; KINBERGER GARTH A; PRAKASH THAZHA P; SETH PUNIT P; SWAYZE ERIC E
    权利人:IONIS PHARMACEUTICALS INC
    摘要:Provided herein are improved methods for the synthesis of reactive conjugate clusters and intermediates used in such methods. In particular, improvements are provided that enhance the synthesis of reactive conjugate clusters by reducing the number of synthetic steps required. The reactive conjugate clusters prepared using the improved methods don't include any transacylation impurities that are formed using existing methods. The improved methods also provide an increase in overall yield and a cost benefit over existing methods.
    苏州润森药物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.rosen-chemicals.com
    企业联系电话:17712495068👤
    📞苏州润森药物科技有限公司 ⚠️参考联系方式
    联系人:杨总
    电话:17712495068
    手机:18751140360
    传真:QQ:640192082
    邮箱:sales@rosen-chemicals.com
    通信地址: 江苏省苏州高新区新亭路5号1幢2楼
    邮编: 235300
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省苏州高新区新亭路5号1幢2楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    安徽兴东化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.shindo-chem.com
    电话:0566-5291586;0519-88120321👤
    📞 安徽兴东化工有限公司⚠️参考联系方式

    电话: 0566-5291586;0519-88120321
    邮件:info@shindo-chem.com
    网址: http://www.shindo-chem.com
    地址:安徽省池州市东至县香隅化工园区
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    安徽省池州市东至县香隅化工园区
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1016/j.intimp.2010.02.004
    摘要:Oh JH, Park EJ, Park JW, Lee J, Lee SH, Kwon TK. A novel cyclin-dependent kinase inhibitor down-regulates tumor necrosis factor-alpha (TNF-alpha)-induced expression of cell adhesion molecules by inhibition of NF-kappaB activation in human pulmonary epithelial cells. Int Immunopharmacol. 2010 May;10(5):572–9. doi: 10.1016/j.intimp.2010.02.004.
    参考文献:10.1021/jm901469p
    摘要:Bernardo PH, Sivaraman T, Wan KF, Xu J, Krishnamoorthy J, Song CM, Tian L, Chin JS, Lim DS, Mok HY, Yu VC, Tong JC, Chai CL. Structural insights into the design of small molecule inhibitors that selectively antagonize Mcl-1. J Med Chem. 2010 Mar 11;53(5):2314–8. doi: 10.1021/jm901469p.
    参考文献:10.1016/j.bpj.2009.10.024
    摘要:Bernal R, Melo F, Pullarkat PA. Drag Force as a Tool to Test the Active Mechanical Response of PC12 Neurites. Biophysical Journal. 2010 Feb;98(4):515–23. doi: 10.1016/j.bpj.2009.10.024.
    参考文献:10.1107/s1600536811007136
    摘要:Akkurt M, Celik I, Demir H, Ozkırımlı S, Büyükgüngör O. N-[2-(4-Chloro-phen-yl)-5-methyl-4-oxo-1,3-thia-zolidin-3-yl]pyridine-3-carboxamide. Acta Crystallogr Sect E Struct Rep Online. 2011 Apr 01;67(Pt 4):o745–6.
    参考文献:10.1107/s1600536811009603
    摘要:Akkurt M, Celik I, Demir H, Ozkırımlı S, Büyükgüngör O. N-[2-(4-Bromo-phen-yl)-5-methyl-4-oxo-1,3-thia-zolidin-3-yl]pyridine-3-carboxamide. Acta Crystallogr Sect E Struct Rep Online. 2011 Apr 01;67(Pt 4):o914–5.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知